Journal of Medicinal Chemistry
Volume 40, Issue 12 (June 6, 1997)
Copyright © 1997
American Chemical Society
1763-1767 | Novel Conformationally Extended Naphthalene-Based Inhibitors of Farnesyltransferase
|
1768-1770 | 9-Benzyladenines: Potent and Selective cAMP Phosphodiesterase Inhibitors
|
1771-1772 | Substituted [(4-Phenylpiperazinyl)- methyl]benzamides: Selective Dopamine D4 Agonists
|
1773-1778 | Synthesis and Biological Evaluation of the Enantiomers of the Potent and Selective A1-Adenosine Antagonist 1,3-Dipropyl-8-[2-(5,6-epoxynorbonyl)]- xanthine
|
1779-1788 | Non-Peptide Glycoprotein IIb/IIIa Inhibitors. 17. Design and Synthesis of Orally Active, Long-Acting Non-Peptide Fibrinogen Receptor Antagonists
|
1789-1793 | Address and Message Sequences for the Nociceptin Receptor: A Structure-Activity Study of Nociceptin-(1-13)-peptide amide
|
1794-1807 | Discovery of a Novel Class of Selective Non-Peptide Antagonists for the Human Neurokinin-3 Receptor. 1. Identification of the 4-Quinolinecarboxamide Framework
|
1808-1819 | Novel and Selective Partial Agonists of 5-HT3 Receptors. 2. Synthesis and Biological Evaluation of Piperazinopyridopyrrolopyrazines, Piperazinopyrroloquinoxalines, and Piperazinopyridopyrroloquinoxalines
|
1820-1826 | Tyrosine Kinase Inhibitors. 12. Synthesis and Structure-Activity Relationships for 6-Substituted 4-(Phenylamino)pyrimido[5,4-d]pyrimidines Designed as Inhibitors of the Epidermal Growth Factor Receptor
|
1827-1834 | Structure-Cytoprotective Activity Relationship of Simple Molecules Containing an  , -Unsaturated Carbonyl System
|
1835-1844 | A Technetium-99m SPECT Imaging Agent Which Targets the Dopamine Transporter in Primate Brain
|
1845-1854 | Synthesis and Anti-HIV Activity of Novel N-1 Side Chain-Modified Analogs of 1-[(2-Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT)
|
1855-1862 | Simulation of Protein-Sugar Interactions: A Computational Model of the Complex between Ganglioside GM1 and the Heat-Labile Enterotoxin of Escherichia coli
|
1863-1869 | Neurotrophic 3,9-Bis[(alkylthio)methyl]- and -Bis(alkoxymethyl)-K-252a Derivatives
|
1870-1875 | Novel Prodrugs of Cyanamide That Inhibit Aldehyde Dehydrogenase in Vivo
|
1876-1885 | Discovery and Biological Activity of Orally Active Peptidyl Trifluoromethyl Ketone Inhibitors of Human Neutrophil Elastase
|
1886-1893 | Structural Studies on Bioactive Compounds. 28. Selective Activity of Triazenyl-Substituted Pyrimethamine Derivatives against Pneumocystis carinii Dihydrofolate Reductase
|
1894-1900 | Design and Synthesis of Potent Antitumor 5,4'-Diaminoflavone Derivatives Based on Metabolic Considerations
|
1901-1905 | Substituted N-Phenylisothioureas: Potent Inhibitors of Human Nitric Oxide Synthase with Neuronal Isoform Selectivity
|
1906-1918 | Dual Inhibition of Human Leukocyte Elastase and Lipid Peroxidation: In Vitro and in Vivo Activities of Azabicyclo[2.2.2]octane and Perhydroindole Derivatives
|
1919-1929 | Structure-Activity Relationships for Acridine-Substituted Analogues of the Mixed Topoisomerase I/II Inhibitor N-[2-(Dimethylamino)ethyl]acridine-4-carboxamide
|
1930-1936 | Synthesis and Biological Activities of Conformationally Restricted, Tricyclic Nonclassical Antifolates as Inhibitors of Dihydrofolate Reductases
|
1937-1939 | Toward a Novel Metal-Based Chemotherapy against Tropical Diseases. 3. Synthesis and Antimalarial Activity in Vitro and in Vivo of the New Gold-Chloroquine Complex [Au(PPh3)(CQ)]PF6
|
1940-1940 | Comprehensive Organic Functional Group Transformations Edited by A. R. Katritzky, O. Meth-Cohn, and C. W. Rees. Pergamon Press (Elsevier Science Ltd.), Tarrytown, NY. 1995. 7 vols., 19.5 × 28 cm. vol. 1, xix + 1420 pp; vol. 2, xix + 1441 pp; vol. 3, xix + 941 pp; vol. 4, xix + 1352 pp; vol. 5, xix + 1442 pp; vol. 6, xix + 933 pp; vol. 7, xvii + 1251 pp. ISBN 0-08-042-322-1; 0-08-042-323-X; 0-08-042-324-8; 0-08-0442-325-6; 0-08-042-326-4; 0-08-042-704-9; 0-08-042-705-7. $4310 (set).
|